EBIT at other companies
Other financials
Where this comes from
Calculated from Gyre Therapeutics, Inc.’s reported figures.
Plus components not separately reported this period.
The official record: Gyre Therapeutics, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Gyre Therapeutics, Inc.'s ebit.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Gyre Therapeutics, Inc.'s EBIT?
- Gyre Therapeutics, Inc. (GYRE) reported EBIT of -$9.36M in Q1 2026.
- How has Gyre Therapeutics, Inc.'s EBIT changed year-over-year?
- Gyre Therapeutics, Inc.'s EBIT decreased by 511.6% year-over-year, from $2.27M to -$9.36M.
- What is the long-term trend for Gyre Therapeutics, Inc.'s EBIT?
- Over 3 years (2021 to 2025), Gyre Therapeutics, Inc.'s EBIT has grown at a -49.3% compound annual growth rate (CAGR), from -$87.89M to $11.49M.
- What does EBIT mean?
- Earnings before interest and taxes — the profit from the business before financing cost and tax. Uses reported operating income where a company reports it; otherwise pre-tax income plus interest expense. Lets companies be compared on earning power independent of capital structure.